Literature DB >> 11390746

Fibrate treatment can increase serum creatinine levels.

V Tsimihodimos, A Kakafika, M Elisaf.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11390746     DOI： 10.1093/ndt/16.6.1301

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN： 0931-0509            Impact factor:   5.992


× No keyword cloud information.
  8 in total

Review 1.  An Increase in Serum Creatinine after Initiation of Fenofibrate in an HIV-Infected Individual: A Case Report and Review of the Literature.

Authors:  Christine B Bruno; Jeffrey M Schapiro; Parya Saberi
Journal:  J Int Assoc Physicians AIDS Care (Chic)       Date:  2011-04-25

Review 2.  Gout in solid organ transplantation: a challenging clinical problem.

Authors:  Lisa Stamp; Martin Searle; John O'Donnell; Peter Chapman
Journal:  Drugs       Date:  2005       Impact factor: 9.546

Review 3.  Fibrate therapy and renal function.

Authors:  Domenic A Sica
Journal:  Curr Atheroscler Rep       Date:  2009-09       Impact factor: 5.113

4.  Analysis of safety from a human clinical trial with pterostilbene.

Authors:  Daniel M Riche; Corey L McEwen; Krista D Riche; Justin J Sherman; Marion R Wofford; David Deschamp; Michael Griswold
Journal:  J Toxicol       Date:  2013-02-04

Review 5.  Management of dyslipidemias with fibrates, alone and in combination with statins: role of delayed-release fenofibric acid.

Authors:  Elisavet Moutzouri; Anastazia Kei; Moses S Elisaf; Haralampos J Milionis
Journal:  Vasc Health Risk Manag       Date:  2010-08-09

Review 6.  A review of time courses and predictors of lipid changes with fenofibric acid-statin combination.

Authors:  Theodosios D Filippatos
Journal:  Cardiovasc Drugs Ther       Date:  2012-06       Impact factor: 3.727

7.  Kidney function and estimated vascular risk in patients with primary dyslipidemia.

Authors:  Konstantinos Tziomalos; Emmanuel S Ganotakis; Irene F Gazi; Devaki R Nair; Dimitri P Mikhailidis
Journal:  Open Cardiovasc Med J       Date:  2009-06-16

Review 8.  Fenofibrate: a novel formulation (Triglide) in the treatment of lipid disorders: a review.

Authors:  Konstantinos Tziomalos; Vasilios G Athyros
Journal:  Int J Nanomedicine       Date:  2006
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.